This secondary offering by selling stockholders is a liquidity event for early investors and private equity sponsors, not a capital raise for the company. Traders should monitor the impact of increased public float on stock volatility and the potential for future secondary offerings. The company's strong financials and market position remain the primary drivers of long-term value.
Executive Summary
Medline Inc. (MDLN) is conducting a secondary offering where selling stockholders are offering 75 million shares of Class A common stock. The company, a leading provider of medical-surgical products and supply chain solutions, reported $28.4 billion in net sales and $1.2 billion in net income for 2025. The offering proceeds go to the selling stockholders, not the company, and follows Medline's initial public offering in December 2025.
Key Financial Metrics
Key Facts
- Selling stockholders are offering 75 million shares of Class A common stock; the company will not receive any proceeds.
- Medline is the largest provider of med-surg products and supply chain solutions, with $28.4 billion in net sales and $1.2 billion in net income for 2025.
- The company operates under an UP-C structure, with Class B common stock holding 76.8% of voting power after the offering.
- The offering includes a potential 11.25 million share over-allotment option for the underwriters.
- The company has a significant tax receivable agreement, with a potential $12.1 billion liability to pre-IPO owners.
Financial Impact
The offering does not generate proceeds for the company. The company reported $28.4 billion in net sales and $1.2 billion in net income for 2025.
Risk Factors
- The UP-C structure gives pre-IPO owners significant control (76.8% voting power), which may conflict with public shareholders' interests.
- The company has a substantial tax receivable agreement liability of $4.0 billion, which could impact future cash flows.
- The company's revenue growth has slowed, with 2025 revenue growth of 11.3% compared to a 13% 10-year CAGR.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1 Filing (Primary) | 0001193125-26-086603 |
| Document: d286688dex11.htm | 0001193125-26-086603 |
| Document: d286688dexfilingfees.htm | 0001193125-26-086603 |
| Document: d286688dex51.htm | 0001193125-26-086603 |
| Document: d286688dex231.htm | 0001193125-26-086603 |
| Document: 0001193125-26-086603-index-headers.html | 0001193125-26-086603 |
| Document: 0001193125-26-086603-index.html | 0001193125-26-086603 |
| Document: 0001193125-26-086603.txt | 0001193125-26-086603 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $36.67 $36.30 | ▼ −1.00% | ▼ −0.39% | $35.61 (−2.88%) |
Aug 5, 2026 8w ago | Press Release | $36.67 $36.30 | ▼ −1.00% | ▼ −0.39% | $35.61 (−2.88%) |
Jul 9, 2026 12w ago | 8-K | $41.04 $35.23 | ▼ −14.16% | ▼ −16.58% | $35.61 (−13.23%) |
Jun 11, 2026 16w ago | Institutional Cluster | $37.13 $40.85 | ▲ +10.02% | ▲ +8.13% | $35.61 (−4.09%) |
Jun 2, 2026 17w ago | 8-K | $33.19 $41.73 | ▲ +25.73% | ▲ +27.30% | $35.61 (+7.29%) |
Jun 1, 2026 17w ago | Insider Cluster | $33.19 $41.73 | ▼ −25.73% | ▼ −27.30% | $35.61 (−7.29%) |
Jun 1, 2026 17w ago | Insider Cluster | $33.19 $41.73 | ▼ −25.73% | ▼ −27.30% | $35.61 (−7.29%) |
May 22, 2026 19w ago | EFFECT | $37.01 $35.31 | ▼ −4.59% | ▼ −3.18% | $35.61 (−3.78%) |
May 22, 2026 19w ago | Press Release | $37.01 $35.31 | ▲ +4.59% | ▲ +3.18% | $35.61 (+3.78%) |
May 20, 2026 19w ago | Press Release | $36.25 $35.94 | ▲ +0.86% | ▲ +1.60% | $35.61 (+1.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access